Insider · CIK 0001560782
James M Daly
Files at CYTK (CYTOKINETICS INC), ACAD (ACADIA PHARMACEUTICALS INC), MDGL (MADRIGAL PHARMACEUTICALS, INC.), HALO (HALOZYME THERAPEUTICS, INC.). First filing Feb 28, 2025, latest Feb 28, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MDGL: MADRIGAL PHARMACEUTICALS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 60Notable | MADRIGAL PHARMACEUTICALS, INC. | $5.4M 15,470 shares | -89% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | HALO HALOZYME THERAPEUTICS, INC. | AGrant or award Restricted Stock Units | +1,169 | $0.00 | $0 | 1,169 | 10 d ago |
| Oct 1, 2026 | HALO HALOZYME THERAPEUTICS, INC. | AGrant or award Option to Purchase Common Stockderivative | +1,775 | $0.00 | $0 | 1,775 | 10 d ago |
| Aug 19, 2025 | CYTK CYTOKINETICS INC | AGrant or award Non-Qualified Stock Option (Right to Buy)derivative | +27,450 | $0.00 | $0 | 27,450 | Aug 20, 2025 |
| Jun 20, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | AGrant or award Common Stock | +715 | $0.00 | $0 | 2,627 | Jun 24, 2025 |
| Jun 20, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +1,290 | $0.00 | $0 | 1,290 | Jun 24, 2025 |
| May 29, 2025 | ACAD ACADIA PHARMACEUTICALS INC | MOption exercise Common Stock | +9,387 | - | - | 34,041 | Jun 2, 2025 |
| May 29, 2025 | ACAD ACADIA PHARMACEUTICALS INC | MOption exercise Restricted Stock Unitsderivative | -9,387 | $0.00 | $0 | 0 | Jun 2, 2025 |
| May 29, 2025 | ACAD ACADIA PHARMACEUTICALS INC | AGrant or award Director Stock Options (Right to Buy)derivative | +13,793 | $0.00 | $0 | 13,793 | Jun 2, 2025 |
| May 29, 2025 | ACAD ACADIA PHARMACEUTICALS INC | AGrant or award Restricted Stock Unitsderivative | +8,107 | $0.00 | $0 | 8,107 | Jun 2, 2025 |
| Feb 27, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Common Stock | +9,470 | $65.06 | $616k | 11,382 | Feb 28, 2025 |
| Feb 27, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Common Stock | +6,000 | $111.06 | $666k | 17,382 | Feb 28, 2025 |
| Feb 27, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -398 | $346.90 | $138k | 16,984 | Feb 28, 2025 |
| Feb 27, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -14,302 | $347.39 | $5.0M | 2,682 | Feb 28, 2025 |
| Feb 27, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -770 | $348.94 | $269k | 1,912 | Feb 28, 2025 |
| Feb 27, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -9,470 | $0.00 | $0 | 0 | Feb 28, 2025 |
| Feb 27, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -6,000 | $0.00 | $0 | 0 | Feb 28, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.